(Q43828479)

27 November 2017

title

Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients (English)

1 reference

27 November 2017

M Salvadori

1

1 reference

27 November 2017

ERLB301 Study Group

series ordinal

2

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Transplantation Proceedings

27 November 2017

published in

1 reference

27 November 2017

volume

33

1 reference

27 November 2017

issue

7-8

1 reference

27 November 2017

page(s)

3245-3247

1 reference

Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902379-X

7 January 2021

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902379-X

7 January 2021

The use of mycophenolate mofetil in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902379-X

7 January 2021

Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902379-X

7 January 2021

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902379-X

7 January 2021

10.1016/S0041-1345(01)02379-X

Identifiers

DOI

1 reference

27 November 2017

1 reference